JUPITERRESEARCH REPORTS THAT BETWEEN 2.0 AND 4.1 MILLION U.S. ADULT INTERNET USERS PURCHASED PRESCRIPTION DRUGS ONLINE FROM FOREIGN OR ROGUE PHARMACIES(New York, NY - June 3, 2004) -- JupiterResearch, a division of Jupitermedia Corporation (Nasdaq: JUPM), announced today that between 2.0 and 4.1 million U.S. adult Internet users purchased prescription drugs online from foreign pharmacies or other sources that are not directly associated with U.S. licensed pharmacies in 2003. About one-half of these consumers used valid prescriptions to purchase their drugs, suggesting that licensed foreign pharmacies were involved. The other half said they either did not use a prescription or used an online questionnaire to obtain their drugs, indicating their purchases were made from rogue pharmacies. By comparison, 19 million U.S. adult Internet users purchased prescription drugs online from U.S. licensed pharmacies that have a Web presence.
The survey also showed that Internet users are highly cautious about using the Web to purchase prescription drugs, making online sales from rogue or foreign pharmacies unlikely to accelerate in the next year. Sixty percent of Internet users cited at least one concern that would prevent them from purchasing prescription drugs online. The most widespread concerns are about the purity of prescription drugs bought online and the proper licensing of the pharmacies used.
However, the Web potentially influences a much larger volume of prescription drug sales from rogue or foreign pharmacies through other channels besides the Web. "Rogue and foreign pharmacies are using the Web as a powerful marketing tool," according to Monique Levy, Health Analyst at JupiterResearch. "As with many other products, consumers can use the Web to research prices and use the phone or fax to actually make their purchases. Pharmaceutical manufacturers and U.S. retailers must factor these other channels in estimating the total impact of foreign and rogue pharmacies on U.S. sales."
The complete findings of this report are immediately available to JupiterResearch clients online. For more information on the report or JupiterResearch's Health research service, please contact Kieran Kelly, Vice President of Global Sales and Client Service at 1-800-481-1212 or [email protected].
About Jupitermedia Corporation
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release which are not historical facts are "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The potential risks and uncertainties address a variety of subjects including, for example, the competitive environment in which Jupitermedia competes; the unpredictability of Jupitermedia's future revenues, expenses, cash flows and stock price; Jupitermedia's ability to integrate acquired businesses, products and personnel into its existing businesses; Jupitermedia's dependence on a limited number of advertisers; and Jupitermedia's ability to protect its intellectual property. For a more detailed discussion of such risks and uncertainties, refer to Jupitermedia's reports filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933 and the Securities Exchange Act of 1934. The forward-looking statements included herein are made as of the date of this press release, and Jupitermedia assumes no obligation to update the forward-looking statements after the date hereof.
All current Jupiter Research press releases can be found online at www.jupitermedia.com/corporate/press.html.
All current Jupitermedia Corporation press releases can be found on the World Wide Web at http://www.jupitermedia.com/corporate/press.html.